{
  "meta": {
    "title": "Mid_Day_Module_Obg-1",
    "url": "https://brainandscalpel.vercel.app/mid-day-module-obg-1-b338cd69.html",
    "scrapedAt": "2025-11-29T18:15:37.337Z"
  },
  "questions": [
    {
      "id": 13312,
      "choices": [
        {
          "id": 53209,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency Cesarean section.</span></p>"
        },
        {
          "id": 53210,
          "text": "<p><span style=\"font-size:12.0pt;\">Induction of labor</span></p>"
        },
        {
          "id": 53211,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic MgSO4</span></p>"
        },
        {
          "id": 53212,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent Ultrasound to see the fetal status</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 22-year Primigravida presents at 34 weeks to the emergency with a BP of 160/110 mmHg. Her urine albumin is 3 +. She is complaining of headache and blurring of vision. On examination, the fetal heart cannot be auscultated. The uterus is relaxed, and a vaginal examination reveals a soft cervix which is 1 cm dilated and 30% effaced. You administer IV labetalol to lower her BP. What is the best immediate next line of management?</span></p>",
      "unique_key": "Q7487843",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Prophylactic MgSO4</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This is a patient with severe preeclampsia with imminent eclampsia with intra-uterine fetal demise</span></li><li><span style=\"font-size:12.0pt;\"><strong>She needs to be delivered but before that, the next best step would be to prevent eclampsia as she is having imminent signs (headache, blurring of vision)</strong></span></li><li><span style=\"font-size:12.0pt;\">Management of Preeclampsia:</span></li><li><span style=\"font-size:12.0pt;\">Definitive treatment is delivery</span></li><li><span style=\"font-size:12.0pt;\">Mild preeclampsia: Termination at 37 weeks</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia</span><ul><li><span style=\"font-size:12.0pt;\">Admit; Consider prophylactic MgSO4</span></li><li><span style=\"font-size:12.0pt;\">Start anti-hypertensives</span></li><li><span style=\"font-size:12.0pt;\">Terminate at 37 weeks or SOS if</span><ul><li><span style=\"font-size:12.0pt;\">Persistent severe HTN&nbsp;</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Eclampsia, HELLP, pulmonary edema, ARF, DIC</span></li><li><span style=\"font-size:12.0pt;\">Fetal compromise&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Abruption</span></li><li><span style=\"font-size:12.0pt;\">Pre-viable fetus</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if &lt; 34 weeks</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is a patient with severe pre-eclampsia with imminent signs of eclampsia (since she has headache and blurring of vision)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The next best step would thus be prophylactic MgSO4 followed by Induction of Labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's analyse the options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Emergency Cesarean Section</strong>: In cases of viable and distressed fetuses, an emergency Cesarean section could be a consideration. However, the indication for an emergency C-section in this scenario is unclear without confirmation of the current fetal status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Induction of Labor:</strong> Induction of labor is generally considered when the fetus is viable and the condition of the mother or fetus necessitates delivery. In this scenario, the status of the fetus is not confirmed, and induction might not be the immediate next step without further assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Prophylactic MgSO4</strong>: This is the correct answer. Given the signs of severe preeclampsia (high BP, proteinuria, headache, and vision changes), administering magnesium sulphate (MgSO4) is crucial for seizure prophylaxis (to prevent eclampsia). This step is important regardless of the fetal status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent Ultrasound to See the Fetal Status</strong>: While an ultrasound is important to assess fetal status, especially since the fetal heart sounds are not audible, the immediate management of severe preeclampsia takes precedence to prevent maternal complications like eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Management of Preeclampsia:</span></li><li><span style=\"font-size:12.0pt;\">Definitive treatment is delivery</span></li><li><span style=\"font-size:12.0pt;\">Mild preeclampsia: Termination at 37 weeks</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia</span><ul><li><span style=\"font-size:12.0pt;\">Admit; Consider prophylactic MgSO4</span></li><li><span style=\"font-size:12.0pt;\">Start anti-hypertensives</span></li><li><span style=\"font-size:12.0pt;\">Terminate at 37 weeks or SOS if</span><ul><li><span style=\"font-size:12.0pt;\">Persistent severe HTN&nbsp;</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Eclampsia, HELLP, pulmonary edema, ARF, DIC</span></li><li><span style=\"font-size:12.0pt;\">Fetal compromise&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Abruption</span></li><li><span style=\"font-size:12.0pt;\">Pre-viable fetus</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Steroids (Betamethasone 12 mg 2 doses 24 h apart IM) for lung maturity if &lt; 34 weeks</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 732, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13316,
      "choices": [
        {
          "id": 53225,
          "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis is made if BP &gt; 140/90 mmHg after 20 weeks in the absence of proteinuria</span></p>"
        },
        {
          "id": 53226,
          "text": "<p><span style=\"font-size:12.0pt;\">5-10% of eclamptic seizures develop in women with gestational hypertension</span></p>"
        },
        {
          "id": 53227,
          "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum</span></p>"
        },
        {
          "id": 53228,
          "text": "<p><span style=\"font-size:12.0pt;\">It is also known as transient hypertension as the BP returns to normal postpartum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding gestational hypertension except?</span></p>",
      "unique_key": "Q9659065",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590356,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. The diagnosis is made only if the blood pressure does not return to normal after 12 weeks postpartum</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Gestational hypertension is defined as hypertension in the absence of proteinuria &gt; 20 weeks.</span></li><li><span style=\"font-size:12.0pt;\">The BP returns to normal after 12 weeks postpartum and is hence also known by some as transient hypertension</span></li><li><span style=\"font-size:12.0pt;\">10% of eclampsia cases is seen in women with gestational HTN</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Classification of HTN in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184021.jpg\" alt=\"\" width=\"1000\" height=\"678\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Let's examine each statement to identify which one is not true about gestational hypertension:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. The Diagnosis is Made if BP &gt; 140/90 mmHg after 20 Weeks in the Absence of Proteinuria</strong>: True. Gestational hypertension is diagnosed when a pregnant woman has blood pressure higher than 140/90 mmHg after 20 weeks of gestation, without the presence of significant proteinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 5-10% of Eclamptic Seizures Develop in Women with Gestational Hypertension</strong>: This statement is misleading. While women with gestational hypertension have an increased risk of developing preeclampsia, which can lead to eclampsia, the exact percentage risk of eclamptic seizures in women with gestational hypertension alone is not well-defined.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zpE4mUe.png\" width=\"1269\" height=\"171\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The Diagnosis is Made Only if the Blood Pressure Does Not Return to Normal after 12 Weeks Postpartum</strong>: False. This statement is incorrect. Gestational hypertension is characterized by high blood pressure during pregnancy that usually resolves postpartum. If high blood pressure persists after 12 weeks postpartum, it suggests chronic hypertension rather than gestational hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is Also Known as Transient Hypertension as the BP Returns to Normal Postpartum: </strong>True. Gestational hypertension is often referred to as transient hypertension of pregnancy because in most cases, the blood pressure normalizes after the delivery of the baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-184135.jpg\" alt=\"\" width=\"1000\" height=\"676\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: page no 711, Williams Obstetrics 25<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13317,
      "choices": [
        {
          "id": 53229,
          "text": "<p><span style=\"font-size:12.0pt;\">An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia.</span></p>"
        },
        {
          "id": 53230,
          "text": "<p><span style=\"font-size:12.0pt;\">A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.</span></p>"
        },
        {
          "id": 53231,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</span></p>"
        },
        {
          "id": 53232,
          "text": "<p><span style=\"font-size:12.0pt;\">Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding predictive tests for preeclampsia except?</span></p>",
      "unique_key": "Q3436563",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590358,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Angiogenic factors sFlt-1 and s-Eng are decreased in women who are at risk of developing preeclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Predictors of preeclampsia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Biophysical markers</strong>: Raised PI in the uterine Artery (11 – 14 weeks); notching of uterine Artery waveform (mid trimester).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Biochemical markers:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-185956.jpg\" alt=\"\" width=\"1000\" height=\"467\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">S-Flt-1 and s-Eng are <strong>Anti-angiogenic factors (Not angiogenic)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Roll over test</strong>: 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test – 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angiotensin II sensitivity test</strong>: Rise in BP with Angiotensin II infusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>**If the patient is at high risk of preeclampsia, low dose aspirin (75-150 mg/ day) should be started before 16 weeks of pregnancy to prevent early onset preeclampsia**</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To understand which statement is not true regarding predictive tests for preeclampsia, let's evaluate each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. An exaggerated diastolic notch is seen beyond 24 weeks on uterine artery Doppler in women at risk for developing pre-eclampsia</strong>: True. An exaggerated diastolic notch in the uterine artery Doppler waveform after 24 weeks of gestation is associated with an increased risk of developing preeclampsia. This finding indicates increased resistance in the uterine arteries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. A drop in levels of PAPP-A and PlGF is a predictor for preeclampsia.</strong>: True. Lower levels of Pregnancy-Associated Plasma Protein-A (PAPP-A) and Placental Growth Factor (PlGF) are associated with an increased risk of preeclampsia. These biomarkers are involved in placental development and function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Angiogenic factors sFlt-1 and s-Eng are increased in women who are at risk of developing preeclampsia</strong>: False. Elevated levels of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (s-Eng) are found in women at risk of developing preeclampsia. However, these are factors are anti-angiogenic and not angiogenic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cell free DNA is increased in women who are at risk of developing preeclampsia due to accelerated apoptosis of cytotrophoblasts</strong>: True. While cell-free DNA levels are increased in certain conditions during pregnancy, such as fetal chromosomal abnormalities (commonly assessed in non-invasive prenatal testing), its direct association with preeclampsia risk due to accelerated apoptosis of cytotrophoblasts is also mentioned in literature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Predictors of preeclampsia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Biophysical markers</strong>: Raised PI in the uterine Artery (11 – 14 weeks); notching of uterine Artery waveform (mid trimester).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Biochemical markers:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-190116.jpg\" alt=\"\" width=\"1000\" height=\"467\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">S-Flt-1 and s-Eng are <strong>Anti-angiogenic factors (Not angiogenic)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Roll over test</strong>: 28- 32 weeks: BP is measured with patient on her side first and then she is asked to roll on her back and BP is checked again -an increase of 20mmHg in diastolic BP from lateral to supine position is a positive test – 30% of such women will develop pre-eclampsia in the future. This test is not done anymore.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angiotensin II sensitivity test</strong>: Rise in BP with Angiotensin II infusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1818, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13323,
      "choices": [
        {
          "id": 53253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop Telmisartan 3 months prior to conception and re-start it at the 3<sup>rd</sup> month of pregnancy</span></span></span></p>"
        },
        {
          "id": 53254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stop Telmisartan 3 months pre-conceptionally and start Labetalol </span></span></span></p>"
        },
        {
          "id": 53255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue Telmisartan </span></span></span></p>"
        },
        {
          "id": 53256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 37-year lady with chronic hypertension visits the gynecologist for pre-conceptional counselling. She is currently taking Telmisartan for her hypertension. Which is the correct statement?</span></span></span></p>",
      "unique_key": "Q5094547",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590362,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preconceptionally, women who are chronic HTN need to be</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Assesses for ventricular hypertrophy, retinopathy and renal disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discuss medicine teratogenicity (ACE-I, ARBs, diuretics and beta blockers are contra-indicated in pregnancy)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Optimize BP control</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch to an agent appropriate for pregnancy (labetalol, calcium channel blockers)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are not formed. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s assess each statement regarding Telmisartan:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Stop Telmisartan 3 months prior to conception and re-start it at the 3rd month of pregnancy</span></strong><span style=\"font-size:12.0pt\">: This advice is incorrect. Telmisartan is an angiotensin receptor blocker (ARB) and is contraindicated in pregnancy due to the risk of causing fetal harm. It should not be restarted during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Stop Telmisartan 3 months pre-conceptionally and start Labetalol</span></strong><span style=\"font-size:12.0pt\">: This is the correct answer. ARBs like Telmisartan are contraindicated in pregnancy due to their association with fetal renal dysplasia, oligohydramnios, and other complications. Labetalol is a safer alternative for managing hypertension in women who are planning to conceive and during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Continue Telmisartan</span></strong><span style=\"font-size:12.0pt\">: Incorrect. ARBs are contraindicated in pregnancy due to potential fetal risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Continue Telmisartan and add Labetalol if BP is uncontrolled in pregnancy</span></strong><span style=\"font-size:12.0pt\">: Incorrect.<strong> </strong>Telmisartan should not be used during pregnancy</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE inhibitors and Angiotensin Receptor Blockers (like Telmisartan) cause fetal renal hypoplasia and lead to early onset oligohydramnios as the fetal kidneys are nor formed and are therefore contra-indicated in pregnancy. &nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Page no 438, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13449,
      "choices": [
        {
          "id": 53757,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 53758,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Postpartum hemorrhage</span></p>"
        },
        {
          "id": 53759,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Acute Fatty liver of Pregnancy</span></p>"
        },
        {
          "id": 53760,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hepatitis B</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Obstetric causes of Acute Kidney Injury (AKI) in pregnancy include all except?</span></p>",
      "unique_key": "Q2400919",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590360,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of AKI in pregnancy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hyperemesis gravidarum</span></li><li><span style=\"font-size:12.0pt;\">Abruptio placenta</span></li><li><span style=\"font-size:12.0pt;\">AFLP</span></li><li><span style=\"font-size:12.0pt;\">Severe preeclampsia/ eclampsia</span></li><li><span style=\"font-size:12.0pt;\">PPH</span></li><li><span style=\"font-size:12.0pt;\">Amniotic fluid embolism</span></li><li><span style=\"font-size:12.0pt;\">Thrombotic microangiopathy</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 2617, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13458,
      "choices": [
        {
          "id": 53793,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Gestational Diabetes</span></span></span></span></p>"
        },
        {
          "id": 53794,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperemesis gravidarum</span></span></span></span></p>"
        },
        {
          "id": 53795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric cholestasis</span></span></span></span></p>"
        },
        {
          "id": 53796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pre-eclampsia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Liver dysfunction is seen in all of the following in pregnancy except?&nbsp; </span></span></span></span></p>",
      "unique_key": "Q7693249",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590369,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. Gestational Diabetes</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144703.jpg\" style=\"height:524px; width:1081px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Reference- Page no 270, DC Dutta&rsquo;s textbook of Obstetrics, 9<sup>th</sup> edition)</span></span></strong></span></span></p>",
      "correct_choice_id": 53793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13328,
      "choices": [
        {
          "id": 53273,
          "text": "<p><span style=\"font-size:12.0pt;\">Cut short the 2<sup>nd</sup> stage of labor</span></p>"
        },
        {
          "id": 53274,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic methylergometrine at the delivery of anterior shoulder</span></p>"
        },
        {
          "id": 53275,
          "text": "<p><span style=\"font-size:12.0pt;\">Restrict IV fluids</span></p>"
        },
        {
          "id": 53276,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin 10U IM following delivery</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All the following precautions are taken in labor in a woman with pre-eclampsia except?</span></p>",
      "unique_key": "Q4767695",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590367,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prophylactic methylergometrine at the delivery of anterior shoulder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Precautions to be taken in labor in women with pre-eclampsia</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Restrict IV fluids to avoid pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cut short 2<sup>nd</sup> stage of labor using instrumental delivery</span></li><li><span style=\"font-size:12.0pt;\">Avoid methylergometrine at delivery of anterior shoulder</span></li><li><span style=\"font-size:12.0pt;\">Active management of 3<sup>rd</sup> stage of labor including Oxytocin 10IU IM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's examine each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cut Short the 2nd Stage of Labor</strong>: True. In cases of pre-eclampsia, it may be necessary to shorten the second stage of labor to reduce stress on the mother. This can be achieved through instrumental delivery if needed and if there are no contraindications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prophylactic Methylergometrine at the Delivery of Anterior Shoulder</strong>: This is the correct answer. Methylergometrine, a uterotonic, is generally avoided in women with pre-eclampsia due to its potential to elevate blood pressure. <strong>The use of methylergometrine is contraindicated in hypertensive disorders due to the risk of exacerbating hypertension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Restrict IV Fluids</strong>: True. Fluid management is critical in pre-eclampsia. Overloading with IV fluids can increase the risk of pulmonary edema, a complication of pre-eclampsia, especially when there is accompanying capillary leakage and reduced plasma oncotic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oxytocin 10U IM following Delivery</strong>: True. Administering oxytocin post-delivery is a standard practice to facilitate uterine contraction and reduce the risk of postpartum haemorrhage. Oxytocin is preferred over ergometrine in pre-eclampsia cases due to its lesser effect on blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Precautions to be taken in labor in women with pre-eclampsia</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Restrict IV fluids to avoid pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Cut short 2<sup>nd</sup> stage of labor using instrumental delivery</span></li><li><span style=\"font-size:12.0pt;\">Avoid methylergometrine at delivery of anterior shoulder</span></li><li><span style=\"font-size:12.0pt;\">Active management of 3<sup>rd</sup> stage of labor including Oxytocin 10IU IM</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: page no 440, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</strong></span></p>",
      "correct_choice_id": 53274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13326,
      "choices": [
        {
          "id": 53265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dhaka regime </span></span></span></p>"
        },
        {
          "id": 53266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sibai regime</span></span></span></p>"
        },
        {
          "id": 53267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magpie regime</span></span></span></p>"
        },
        {
          "id": 53268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zuspan regime</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are regimes of MgSO4 for treatment of eclampsia except?</span></span></p>",
      "unique_key": "Q2067839",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Magpie regime</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Various regimes of MgSO4 for eclampsia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pritchard Regime (most commonly used in India)</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Initial dose: 20% MgSo4- 4g IV slowly over 4 mins (1g/min) as 20 ml followed by 5g in each buttock as 10ml of 50%MgSO4</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maintenance dose: 5g of 50% MgSO4 IM in alternate buttocks 4 hourly till 24 h or till delivery, whichever is later. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sibai regime: </span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose 6g MgSO4 IV over 15 &ndash; 20 mins f/b IV infusion 2g/ h as maintenance dose </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recommended by ACOG</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Zuspan Regime</span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose 4g IV MgSO4 f/b IV infusion of 1g/ h until 24 h after delivery</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dhaka regime</span></strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lower dose of MgSO4 (Half of Pritchard&rsquo;s)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loading dose is 4g IV over 15 mins</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Following this, 3 g MgSO4 IM in each buttock 4 hourly for 24 h after administration of 1<sup>st</sup> dose. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This regime was developed with South-East Asian women&rsquo;s smaller body habitus in mind to reduce the risk of Mg toxicity as compared to Pritchard regime. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magpie is not a regime. It was a large multicentric study to determine the usefulness of MgSO4 for prophylaxis for eclampsia in women with severe preeclampsia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key educational takeaway is that while there are several recognized regimens for the administration of magnesium sulfate in the management of eclampsia (like the Dhaka, Sibai, and Zuspan regimens), the &quot;Magpie regime&quot; is not one of them.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Instead, the Magpie Trial was a significant research study that helped establish the effectiveness of magnesium sulfate in this context. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13334,
      "choices": [
        {
          "id": 53297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creatinine levels 1.24mg/dl</span></span></span></p>"
        },
        {
          "id": 53298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Platelet counts 154000/microL</span></span></span></p>"
        },
        {
          "id": 53299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alkaline phosphatase 142 IU/L</span></span></span></p>"
        },
        {
          "id": 53300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total protein of 252mg in a 24-hour urine collection</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A multiparous patient who did not attend any antenatal visit and came to causality with complaint of bleeding. On examination uterine tone was increased with BP&gt;144/92 mmHg. Which of the following tests supports the diagnosis of preeclampsia?</span></span></span></p>",
      "unique_key": "Q4501433",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590373,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Creatinine levels 1.24mg/dl</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia is&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">a pregnancy specific syndrome that can affect virtually every organ system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s assess each option based on the above explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Creatinine levels 1.24 mg/dl:</span></strong><span style=\"font-size:12.0pt\"> This is the correct answer. Elevated creatinine levels can be indicative of kidney dysfunction, which is one of the organ systems affected in preeclampsia. Kidney dysfunction can manifest as an increase in creatinine levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Platelet Counts 154,000:</span></strong><span style=\"font-size:12.0pt\"> Thrombocytopenia (a low platelet count) can occur in preeclampsia, but this value (154,000/microL) is within the normal range for platelet counts. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Alkaline Phosphatase 142 IU/L</span></strong><span style=\"font-size:12.0pt\">: Elevated alkaline phosphatase levels are not a specific marker for preeclampsia. Alkaline phosphatase levels can be affected by various conditions, including liver disorders, but they are not a primary diagnostic criterion for preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Total Protein of 252 mg in a 24-Hour Urine Collection</span></strong><span style=\"font-size:12.0pt\">: While increased proteinuria is a hallmark of preeclampsia, the total protein value of 252 mg in a 24-hour urine collection is is less than the cut off of 300 mg.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preeclampsia Definitions</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\">Preeclampsia</span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertension and proteinuria&nbsp;<strong>or</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In absence of proteinuria, new-onset hypertension with the new onset of any of the following</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombocytopenia: Platelets &lt;100 x 10<sup>9</sup>/L</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal insufficiency: serum creatinine &gt;1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Impaired liver function: Elevated blood concentrations of liver transaminases to twice normal concentration</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis)&nbsp;<strong>or&nbsp;</strong>visual symptoms</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\">Preeclampsia with severe features</span></em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preeclampsia diagnosis, above, with any of the following</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe hypertension</span></span></span>\r\n\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">On two occasions at least 4 hours apart while on bed rest (unless already on antihypertensive therapy)</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombocytopenia: Platelets &lt;100 x 10<sup>9</sup>/L</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Impaired liver function (without an alternative diagnosis): Elevated liver transaminases greater than twice upper limit of normal&nbsp;<strong>or</strong>&nbsp;severe persistent right upper quadrant&nbsp;<strong>or</strong>&nbsp;epigastric pain not responsive to medications</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progressive renal insufficiency: serum creatinine &gt;1.1 mg/dl or doubling of serum creatinine in the absence of other renal disease</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuro: Unexplained new-onset headache unresponsive to medication (without an alternative diagnosis)&nbsp;<strong>or&nbsp;</strong>visual symptoms</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:&nbsp;</span></strong><span style=\"font-size:12.0pt\">The following are&nbsp;<em>not</em>&nbsp;diagnostic criteria for the diagnosis of preeclampsia or preeclampsia with severe features</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clinically evident edema</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rapid weight gain</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Massive proteinuria</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Does not qualify as a &lsquo;severe feature&rsquo;</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fetal growth restriction</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Expectant management &lsquo;may be reasonable&rsquo; if mother and fetus appear stable and no other clinical indication is present that would indicate the need for early delivery ACOG states that while it is important to monitor fetal status, FGR in the setting of all other fetal assessment being within normal limits (e.g., AFV, Doppler)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uric acid</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperuricemia in hypertensive pregnancy is not a diagnostic marker, but is an important finding as a risk factor for adverse maternal and fetal outcomes</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small for gestational age (SGA) infant</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prematurity</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Risk for adverse maternal outcomes if include patients with preeclampsia and risks increase with increasing concentration of uric acid</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">May be warranted in the setting of &lsquo;diagnostic dilemmas&rsquo; such as diagnosing superimposed preeclampsia in the setting of chronic hypertension</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>https://www.preeclampsia.org/frontend/assets/img/advocacy_resource/Gestational_Hypertension_and_Preeclampsia_ACOG_Practice_Bulletin,_Number_222_1605448006.pdf</strong></span></span></span></p>",
      "correct_choice_id": 53297,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13446,
      "choices": [
        {
          "id": 53745,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine should be administered within 24 hours of birth&nbsp;</span></p>"
        },
        {
          "id": 53746,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">HBIG should be administered within 12 hours of birth.&nbsp;</span></p>"
        },
        {
          "id": 53747,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine and HBIG should be administered within 12 hours of birth&nbsp;</span></p>"
        },
        {
          "id": 53748,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hep-B Vaccine and HBIG should be administered within 24 hours of birth&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 30y primigravida presents in labor at 38 weeks. The resident notes that she is HBsAg positive. Which of the following statements regarding immunization of a newborn born to a HBsAg positive mother is true?</span></p>",
      "unique_key": "Q3507898",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Hep-B Vaccine and HBIG should be administered within 12 hours of birth)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Newborn of HBSAg positive mothers: The following has to be given to reduce the risk of Hepatitis B in the neonate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Hepatitis B Immunoglobulin (HBIG) 0.5 ml IM (intramuscular) within 12 hours of birth</span></li><li><span style=\"font-size:16px;\">Active immunization with Hep B vaccine (0.5 ml) IM at a separate site at birth.</span></li><li><span style=\"font-size:16px;\">Passive + Active immunization: 85 – 95% effective in preventing transmission.</span></li><li><span style=\"font-size:16px;\">Breastfeeding is not contra-indicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jAaFs84.png\" width=\"1033\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Vaccination schedule of hepatitis B vaccine&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GvIZhju.png\" width=\"708\" height=\"288\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Reference: Williams Obstetrics 25<sup>th</sup> edition Page 1065</strong></span></p>",
      "correct_choice_id": 53747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13329,
      "choices": [
        {
          "id": 53277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preeclampsia</span></span></span></p>"
        },
        {
          "id": 53278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic hypertension with superimposed preeclampsia</span></span></span></p>"
        },
        {
          "id": 53279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eclampsia</span></span></span></p>"
        },
        {
          "id": 53280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gestational hypertension</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 32-year-old primigravida at 39 weeks has a BP recording of 150/100 which when repeated is the same. Her baseline BP during earlier visits was 120/80 mmHg. She does not complain of headache/ blurring of vision or epigastric pain. Abdominal exam reveals a term uterus with cephalic presentation and FHR of 140 bpm. Urine albumin is nil. Which is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q3598446",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590368,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Gestational hypertension&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension in pregnancy is defined as blood pressure of 140/90 mmHg or greater on at least two separate occasions that are 6 h or more apart. The presence of edema is no longer used as a diagnostic criterion because it is so prevalent in normal pregnant women. A rise in systolic blood pressure of 30 mmHg and a rise in diastolic blood pressure of 15 mmHg are also no longer used.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In <strong><em>gestational hypertension,</em></strong> maternal blood pressure reaches 140/90 or greater for the first time during pregnancy, and proteinuria is not present. In <strong><em>preeclampsia,</em></strong> blood pressure increases to 140/90 after 20 weeks of gestation and proteinuria is present (300 mg in 24 h or 1+ protein or greater on dipstick). <strong><em>Eclampsia </em></strong>is present when women with preeclampsia develop seizures.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic hypertension</span></em></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is defined as BP &gt;140/90 mmHg before pregnancy or diagnosed before 20 weeks of gestation, or hypertension first diagnosed after 20 weeks of gestation and persistent after 12 weeks postpartum.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A woman with hypertension who develops preeclampsia is described as having chronic hypertension with superimposed preeclampsia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s analyse each option based on the provided scenario:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: In this case, the woman does not have proteinuria or other systemic symptoms, making preeclampsia less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chronic Hypertension with Superimposed Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: The patient&#39;s baseline BP was normal during earlier visits, which does not suggest chronic hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Eclampsia</span></strong><span style=\"font-size:12.0pt\">: There is no mention of seizures or convulsions in this scenario, ruling out eclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gestational Hypertension</span></strong><span style=\"font-size:12.0pt\">: This is the correct diagnosis. The woman has new-onset hypertension at 39 weeks without proteinuria or other symptoms suggestive of preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Gestational hypertension is characterized by new-onset hypertension after 20 weeks of gestation without proteinuria or other systemic findings associated with preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page 1780, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13320,
      "choices": [
        {
          "id": 53241,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">7 mEq/L</span></p>"
        },
        {
          "id": 53242,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">10 mEq/L</span></p>"
        },
        {
          "id": 53243,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">12 mEq/L</span></p>"
        },
        {
          "id": 53244,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">14 mEq/L</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patellar reflexes disappear when the plasma magnesium level reaches:</span></p>",
      "unique_key": "Q1542034",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590359,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 10 mEq/L</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Eclamptic convulsions are almost always prevented or arrested by plasma magnesium levels maintained at 4 – 7 mEq/L (Equivalent to 4.8 -8.4 mg/dl or 2.0 – 3.5 mmol/L)</span></li><li><span style=\"font-size:12.0pt;\">In women on MgSO4 for treatment of eclampsia/ severe pre-eclampsia, they have to be monitored very carefully for signs of Mg toxicity</span></li><li><span style=\"font-size:12.0pt;\">Mg toxicity is a cause for concern</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hxDBECp.png\" width=\"1120\" height=\"337\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Remember: Disappearance of Deep tendon (Patellar) reflexes are the 1<sup>st</sup> sign of Mg toxicity</span></li><li><span style=\"font-size:12.0pt;\">Antidote: Calcium gluconate or calcium chloride – 1 g IV</span></li><li><span style=\"font-size:12.0pt;\">Monitoring of patient on MgSO4: Check</span><ol><li><span style=\"font-size:12.0pt;\">Patellar reflex</span></li><li><span style=\"font-size:12.0pt;\">Respiratory Rate</span></li><li><span style=\"font-size:12.0pt;\">Urine output (Mg is excreted through the kidneys, so ARF can impair Mg excretion leading to Mg toxicity)</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Monitoring for magnesium toxicity is crucial when administering magnesium sulfate, especially in obstetric settings for conditions like preeclampsia or eclampsia.</span></li><li><span style=\"font-size:12.0pt;\">The loss of deep tendon reflexes, such as the patellar reflex, is the first clinical sign and usually occurs at plasma magnesium levels around 10 mEq/L.</span></li></ul>",
      "correct_choice_id": 53242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13314,
      "choices": [
        {
          "id": 53217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 300 mg/ 24 h</span></span></span></span></p>"
        },
        {
          "id": 53218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 30 mg/24 h</span></span></span></span></p>"
        },
        {
          "id": 53219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 3 mg/24 h</span></span></span></span></p>"
        },
        {
          "id": 53220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">&ge; 0.3mg/ 24h</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To define preeclampsia, the proteinuria defined is?</span></span></p>",
      "unique_key": "Q1629168",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590353,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. &ge; 300 mg/ 24 h</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pre-eclampsia is defined as Hypertension plus </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proteinuria &ge; 300 mg/ 24h or </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine protein: creatinine ratio &ge; 0.3 or</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dipstick 1+ or more</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">But remember, for severity of preeclampsia, proteinuria is no longer a parameter</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The diagnosis of preeclampsia involves assessing for the presence of hypertension and significant proteinuria, defined as the excretion of 300 mg or more of protein in a 24-hour urine collection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Page no 712, Williams Obstetrics 25<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13452,
      "choices": [
        {
          "id": 53769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Immediate induction of labor</span></span></span></span></p>"
        },
        {
          "id": 53770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emergency LSCS</span></span></span></span></p>"
        },
        {
          "id": 53771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitor BP and plan delivery at 37 weeks</span></span></span></span></p>"
        },
        {
          "id": 53772,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Weekly LFT and plan delivery at 38 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 27-year G2P1L1 presents at 33 weeks with itching mainly on the palms of her hands. The itching worsens at night. She gives a similar history in her 1<sup>st</sup> pregnancy. On examination, her BP is 130/84 mmHg. There is mild icterus and abdominal examination reveals a 32 weeks uterus with fetal heart rate of 140 bpm. Her SGOT is 112 IU/L, SGPT is 124 IU/L and serum bilirubin is 2 mg%. What is the next best step in management? </span></span></span></p>",
      "unique_key": "Q3712596",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590363,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D. Weekly LFT and plan delivery at 38 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The diagnosis is Obstetric cholestasis </span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Management</span></span></strong></span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic relief: </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">mollients, Antihistamine, Ursodeoxycholic acid (Relieves pruritus, lowers bile acid and serum liver enzyme levels)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Management </span></span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitoring with weekly LFT, PT-INR</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If PT-INR prolonged &ndash; offer vitamin K </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Induction of Labor at 38 weeks</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum and Intrapartum fetal monitoring</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference: - Williams Obstetrics 25<sup>th</sup> edition, Page no 1060</span></span></strong></span></span></p>",
      "correct_choice_id": 53772,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13340,
      "choices": [
        {
          "id": 53321,
          "text": "<p><span style=\"font-size:12.0pt;\">Conservative management with anti-hypertensives</span></p>"
        },
        {
          "id": 53322,
          "text": "<p><span style=\"font-size:12.0pt;\">Delivery after 34 weeks of gestation</span></p>"
        },
        {
          "id": 53323,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate delivery</span></p>"
        },
        {
          "id": 53324,
          "text": "<p><span style=\"font-size:12.0pt;\">Declare fetal demise</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A Primigravida presents at 32 weeks with pre-eclampsia. She complains of decreased fetal movements. An umbilical artery Doppler is done which is as shown in the image. What is the next best step in management?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:11.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture3.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p>",
      "unique_key": "Q1785759",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590374,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Immediate delivery</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given UA Doppler shows reversal of end diastolic flow, which is suggestive of impending fetal demise – so the immediate management is Delivery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's evaluate each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Conservative Management with Anti-Hypertensives</strong>: While controlling maternal hypertension is important in pre-eclampsia, the primary concern in this scenario is the well-being of the fetus due to decreased movements. Conservative management alone may not address the fetal distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Delivery After 34 Weeks of Gestation</strong>: The decision to delay delivery depends on the overall condition of both the mother and the fetus. Reversal of diastolic flow shows fetal distress and waiting until 34 weeks may not be appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Immediate Delivery</strong>: In the presence of pre-eclampsia, decreased fetal movements and doppler suggestive of reversal of flow, immediate delivery is often indicated to ensure the well-being of the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Declare Fetal Demise:</strong> This statement is not true. Immediate delivery can prevent fetal demise</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immediate delivery is often indicated when there are signs of fetal distress, as it is essential to ensure the well-being of the fetus. &nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Reversal of diastolic flow in the umbilical artery &nbsp;raises concerns about fetal compromise, and immediate &nbsp;delivery is crucial</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref:&nbsp; Page no 1840, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13325,
      "choices": [
        {
          "id": 53261,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha-methyldopa</span></p>"
        },
        {
          "id": 53262,
          "text": "<p><span style=\"font-size:12.0pt;\">Captopril</span></p>"
        },
        {
          "id": 53263,
          "text": "<p><span style=\"font-size:12.0pt;\">Enalapril</span></p>"
        },
        {
          "id": 53264,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Anti-hypertensives contra-indicated in pregnancy are all except?</span></p>",
      "unique_key": "Q6306628",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590372,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Alpha-methyldopa</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Anti-hypertensives:</strong></span><ul><li><span style=\"font-size:12.0pt;\">DOC: Labetalol (Max oral dose 2400mg/d); can be given IV in emergencies (Max IV dose is 220 mg)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alpha methyl dopa: Greatest safety data available</strong>, 48 h for onset of action</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine: CCB, short acting, oral (S/l is c/i) used in emergencies</span></li><li><span style=\"font-size:12.0pt;\">Hydralazine: for emergencies, IV</span></li><li><span style=\"font-size:12.0pt;\">Diuretics: only if pulmonary edema</span></li><li><span style=\"font-size:12.0pt;\">Beta blockers: long term use causes Growth restriction, not preferred</span></li><li><span style=\"font-size:12.0pt;\">ACE inhibitors and ARB – <strong>ABSOLUTE C/I</strong> in pregnancy as they cause fetal renal anomalies.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's evaluate the options provided:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alpha-methyldopa</strong>: Alpha-methyldopa is considered safe and is one of the preferred antihypertensive medications during pregnancy. It has been widely used for many years without significant adverse effects on the fetus. Alpha-methyldopa is not contraindicated in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Captopril</strong>: Captopril, an ACE inhibitor, is contraindicated in pregnancy, especially in the second and third trimesters, due to the risk of fetal renal dysplasia, oligohydramnios, and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Enalapril</strong>: Enalapril is another ACE inhibitor, and like captopril, it is contraindicated in pregnancy for the same reasons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Losartan</strong>: Losartan is an angiotensin receptor blocker (ARB) and is also contraindicated in pregnancy. ARBs have been associated with adverse fetal outcomes similar to those of ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The anti-hypertensive drug of choice in pregnancy is labetalol</span></li><li><span style=\"font-size:12.0pt;\">Alpha-methyldopa is considered safe and is one of the preferred anti hypertensives in pregnancy.</span></li><li><span style=\"font-size:12.0pt;\">However, ACE inhibitors (like captopril and enalapril) and ARBs (like losartan) are contraindicated due to their potential adverse effects on the developing fetus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 438, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13331,
      "choices": [
        {
          "id": 53285,
          "text": "<p><span style=\"font-size:12.0pt;\">New onset proteinuria</span></p>"
        },
        {
          "id": 53286,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet count &lt; 75,000</span></p>"
        },
        {
          "id": 53287,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</span></p>"
        },
        {
          "id": 53288,
          "text": "<p><span style=\"font-size:12.0pt;\">Fresh retinal hypertensive changes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">All of the following indicate superimposed pre-eclampsia in a pregnant female of chronic hypertension except:</span></p>",
      "unique_key": "Q7813793",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590370,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Increase in systolic BP by 30mm Hg and diastolic by 15 mm Hg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-192932.jpg\" alt=\"\" width=\"1000\" height=\"455\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Let's assess each option to determine which one does not indicate superimposed pre-eclampsia:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. New Onset Proteinuria</strong>: The development of new-onset proteinuria in a pregnant woman with chronic hypertension can be a sign of superimposed pre-eclampsia. It is one of the criteria for diagnosing this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Platelet Count &lt; 75,000</strong>: A significant drop in platelet count, known as thrombocytopenia, can be an indication of superimposed pre-eclampsia. It is a concerning feature associated with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Increase in Systolic BP by 30 mm Hg and Diastolic by 15 mm Hg</strong>: This is the correct answer. An increase in systolic blood pressure by 30 mm Hg and diastolic blood pressure by 15 mm Hg from baseline <strong>may indicate worsening hypertension in a pregnant woman but does not specifically indicate superimposed pre-eclampsia. Instead, it suggests poorly controlled chronic hypertension or exacerbation of hypertension.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Fresh Retinal Hypertensive Changes</strong>: The presence of fresh retinal hypertensive changes is a concerning sign and may indicate superimposed pre-eclampsia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of chronic HTN with superimposed preeclampsia is made when a woman with chronic essential hypertension develops any of the above maternal organ dysfunction consistent with preeclampsia. Rises in BP per se are not sufficient to diagnose superimposed preeclampsia, as such rises are difficult to distinguish from the usual increase in BP after 20 weeks’ gestation. In the absence of preexisting proteinuria, new-onset proteinuria in the setting of a rise in BP is sufficient to diagnose superimposed preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/screenshot-2024-01-08-193029.jpg\" alt=\"\" width=\"1000\" height=\"455\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 1780, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13319,
      "choices": [
        {
          "id": 53237,
          "text": "<p><span style=\"font-size:12.0pt;\">Low salt diet</span></p>"
        },
        {
          "id": 53238,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium supplementation started prior to 12 weeks</span></p>"
        },
        {
          "id": 53239,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin 150 mg/ day prior to 16 weeks</span></p>"
        },
        {
          "id": 53240,
          "text": "<p><span style=\"font-size:12.0pt;\">Antioxidants – ascorbic acid and α-tocopherol prior to 12 weeks</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 35-year primigravida is worried about her risk of developing preeclampsia. What is the single most important intervention to help reduce the risk in her?</span></p>",
      "unique_key": "Q8764778",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590366,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Aspirin 150 mg/ day prior to 16 weeks</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The RCOG and US preventive Services task force recommends low dose aspirin (up to 150mg/ day) prophylaxis for women at high risk for pre-eclampsia.</span></li><li><span style=\"font-size:12.0pt;\">Aspirin is the <strong>ONLY </strong>recommended measure for prevention of pre-eclampsia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">let's evaluate the proposed interventions:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Low Salt Diet</strong>: While general healthy eating is recommended during pregnancy, there's no strong evidence that a low salt diet specifically reduces the risk of preeclampsia. Traditional advice often suggested this, but recent studies have not supported it as an effective preventative measure for preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Calcium Supplementation Started Prior to 12 Weeks</strong>: Calcium supplementation can be beneficial in reducing the risk of preeclampsia, particularly in women with low dietary calcium intake. However, it's not typically highlighted as the primary preventive measure in women with a standard risk profile for preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aspirin 150 mg/ day Prior to 16 Weeks</strong>: This is the correct answer. Low-dose aspirin (usually around 75-150 mg per day) started before 16 weeks of gestation has been shown to reduce the risk of preeclampsia, especially in women with certain risk factors. Aspirin helps by improving uteroplacental blood flow and reducing inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antioxidants – Ascorbic Acid and α-tocopherol Prior to 12 Weeks</strong>: Although the theory behind using antioxidants like vitamin C (ascorbic acid) and vitamin E (α-tocopherol) to prevent preeclampsia is related to reducing oxidative stress, clinical trials have not consistently shown these supplements to be effective in reducing the risk of preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Low-dose aspirin started before 16 weeks of gestation is a recommended intervention to reduce the risk of developing preeclampsia, particularly for women at high risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 1825, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 53239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13322,
      "choices": [
        {
          "id": 53249,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 53250,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
        },
        {
          "id": 53251,
          "text": "<p><span style=\"font-size:12.0pt;\">Captopril</span></p>"
        },
        {
          "id": 53252,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25-year-old P2L2 had just delivered following induction for severe preeclampsia. Her BP on the 2<sup>nd</sup> postnatal day is 160/100mmHg. Which anti-hypertensive should be avoided in a breastfeeding mother?</span></p>",
      "unique_key": "Q9265562",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Amlodipine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with no known adverse effects on infants receiving breast milk:<strong> Mnemonic: ECLAM-N</strong></span><ul><li><span style=\"font-size:12.0pt;\">Enalapril</span></li><li><span style=\"font-size:12.0pt;\">Captopril</span></li><li><span style=\"font-size:12.0pt;\">Labetalol</span></li><li><span style=\"font-size:12.0pt;\">Atenolol</span></li><li><span style=\"font-size:12.0pt;\">Metoprolol</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with insufficient evidence on infant safety in breast-feeding (not recommended in breast feeding mothers):</span><ul><li><span style=\"font-size:12.0pt;\">Angiotensin receptor blocking agents</span></li><li><span style=\"font-size:12.0pt;\">Amlodipine</span></li><li><span style=\"font-size:12.0pt;\"><strong>ACE-Inhibitors (Except enalapril and captopril)</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Let's review each option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amlodipine</strong>: Amlodipine, a calcium channel blocker, is generally not the preferred choice in breastfeeding mothers. This is the correct answer. Given the limited data and the existence of safer alternatives, amlodipine is often avoided or used with caution in breastfeeding mothers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Labetalol</strong>: Labetalol, a beta-blocker, is considered safe for use in breastfeeding mothers. It does not significantly pass into breast milk and is commonly used for managing hypertension in postpartum women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Captopril</strong>: Captopril, an ACE inhibitor, is generally considered safe in breastfeeding mothers. Captopril can be used for managing hypertension in a breastfeeding mother, though close monitoring is recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nifedipine</strong>: Nifedipine, another calcium channel blocker, is considered safe for use in breastfeeding mothers. It is excreted into breast milk in small amounts and is commonly used in postpartum hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Antihypertensive agents with no known adverse effects on infants receiving breast milk:<strong> Mnemonic: ECLAM-N</strong></span><ul><li><span style=\"font-size:12.0pt;\">Enalapril</span></li><li><span style=\"font-size:12.0pt;\">Captopril</span></li><li><span style=\"font-size:12.0pt;\">Labetalol</span></li><li><span style=\"font-size:12.0pt;\">Atenolol</span></li><li><span style=\"font-size:12.0pt;\">Metoprolol</span></li><li><span style=\"font-size:12.0pt;\">Nifedipine</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Smith, M&nbsp;,&nbsp;Waugh, J,&nbsp;Nelson‐Piercy, C&nbsp;Management of postpartum hypertension&nbsp;The Obstetrician &amp; Gynecologist&nbsp;2013;&nbsp;15:&nbsp;45–&nbsp;50</strong></span></p>",
      "correct_choice_id": 53249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13450,
      "choices": [
        {
          "id": 53761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is the most common cause of jaundice in pregnancy</span></span></span></span></p>"
        },
        {
          "id": 53762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Itching is typically present on the palms and soles</span></span></span></span></p>"
        },
        {
          "id": 53763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The recurrence rate in subsequent pregnancies is up to 50%</span></span></span></span></p>"
        },
        {
          "id": 53764,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is associated with meconium staining of amniotic fluid and fetal death</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is incorrect regarding Obstetric Cholestasis?</span></span></span></p>",
      "unique_key": "Q3831714",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590361,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. It is the most common cause of jaundice in pregnancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Cholestasis-</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">2<sup>nd</sup> most common cause of jaundice in pregnancy (after viral hepatitis)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Clinical Features- </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Commonly presents in the: 3<sup>rd</sup> trimester</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pruritus </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Main symptom</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Generalized but more common on soles and palms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most severe at night</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Slight jaundice; Associated dark urine, pale stools, steatorrhea and malaise may be seen</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Investigations- </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mildly raised SGOT/ SGPT (usually less than 500)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Moderately elevated ALP (Alkaline phosphatase)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Moderately elevated serum bilirubin (up to 5 mg %)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Raised serum bile acids</span></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Most specific investigation</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Values &gt; 10&micro;mol/L &ndash; indicative of increased levels; </span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Values &gt; 40&micro;mol/L &ndash; associated with poor perinatal outcome</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Effect on Pregnancy -</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Meconium-stained amniotic fluid; Fetal distress; Stillbirths; Increased perinatal mortality rate</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Management-</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Symptomatic relief </span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Emollients</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antihistamine</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ursodeoxycholic acid: Relieves pruritus, lowers bile acid and serum liver enzyme levels</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Obstetric Management </span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Monitoring with weekly Liver function test</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">If PT-INR prolonged &ndash; offer vitamin K </span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Induction of Labor at 38 weeks can be considered.</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Antepartum and Intrapartum fetal monitoring</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:120px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Post Delivery</span></span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Repeat LFT at 6 weeks postpartum</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Avoid Estrogen containing contraceptives</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrence rate in subsequent pregnancy: high (50 &ndash; 60%)</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:120px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference-: Page 1059, Williams Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 53761,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30493,
      "choices": [
        {
          "id": 121850,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassure and advise symptomatic treatment</span></span></p>"
        },
        {
          "id": 121851,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prescribe antibiotics</span></span></p>"
        },
        {
          "id": 121852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Order Zika virus testing</span></span></span></p>"
        },
        {
          "id": 121853,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate antiviral therapy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman in her first trimester presents with fever, rash, and</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> arthralgia. She recently returned from a trip to a region where Zika virus is endemic. What is the most appropriate next step?</span></span></p>",
      "unique_key": "Q7082989",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Order Zika virus testing</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Given her symptoms and travel history, testing for Zika virus is crucial due to the risk of congenital Zika syndrome, which can cause microcephaly and other severe fetal brain defects. Testing is done by detecting Zika virus RNA by PCR in blood or urine. It is vector borne (mosquito).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika virus in pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This RNA flavivirus is the first major mosquito-borne teratogen recognized </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika virus is primarily transmitted by mosquito bite, but sexual transmission is possible.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Maternal-Fetal Infection: </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zika infection is asymptomatic in approximately 80 percent of adults.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may cause mild rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The fetus can be severely infected whether the mother is symptomatic.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the most severely affected fetuses, a congenital Zika syndrome has been described that includes microcephaly, lissencephaly, ventriculomegaly, intracranial calcifications, ocular abnormalities, and congenital contractures</span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis and Management. </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laboratory testing for Zika infection is recommended in symptomatic gravidas with residence in or recent travel to areas with active dengue transmission and risk for Zika transmission </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum IgM antibodies typically become detectable within the first 2 weeks and may persist for months. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a pregnant woman within 12 weeks of symptom onset, PCR testing of serum and urine specimens for both dengue and Zika virus RNA is recommended. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For women with prenatal ultrasound findings suggesting congenital Zika syndrome, Zika virus PCR and IgM are initially performed on serum and urine. Amnionic fluid PCR may be performed, although less is known about its diagnostic accuracy for congenital infection.</span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Currently, no specific treatment or vaccine is available for Zika infection, although several vaccines are in development </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Williams Textbook of Obstetrics 26<sup>th</sup> edition pg 3107</span></strong></span></span></p>",
      "correct_choice_id": 121852,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13442,
      "choices": [
        {
          "id": 53729,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It is associated with high fetal and maternal morbidity and mortality&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 53730,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Commonly occurs in the 2<sup>nd</sup> trimester&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 53731,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">It has an association with gestational diabetes mellitus</span></span></span></span></p>"
        },
        {
          "id": 53732,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Less common in multiple pregnancies</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is true about Acute fatty liver of pregnancy? </span></span></span></p>",
      "unique_key": "Q4685840",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590354,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A. It is associated with high fetal and maternal morbidity and mortality&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Acute Fatty Liver of Pregnancy- </span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The most frequent cause of acute liver failure during pregnancy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">1 in 10000 pregnancies</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Recurrence &ndash; rare</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/screenshot-2023-04-30-144450.jpg\" style=\"height:634px; width:1267px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AFLP is diagnosed by Swansea criteria where 6 out of 14 criteria are required to diagnose AFLP</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AFLP: Swansea diagnostic criteria</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">(Six or more in the absence of other explanation)</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Vomiting </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Abdominal pain</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Polydipsia/polyuria</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Encephalopathy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High bilirubin &gt; 15 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypoglycemia &lt; 4 mmol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High uric acid &gt; 340 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Leukocytosis &gt; 11x10<sup>6</sup>/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ascites or bright liver on ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High AST/ALT &gt; 42 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">High ammonia &gt;47 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Renal impairment with creatinine &gt; 150 micromol/L</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Coagulopathy PT &gt; 14 sec</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Microvesicular steatosis on liver biopsy</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Reference- Williams Obstetrics 25<sup>th</sup> edition, Page no 1061</span></span></strong></span></span></p>",
      "correct_choice_id": 53729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13444,
      "choices": [
        {
          "id": 53737,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Kidney increases in pregnancy by about 1.5 cm</span></span></span></span></p>"
        },
        {
          "id": 53738,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Pelvicalyceal dilatation is more on the left side than the right side</span></span></span></span></p>"
        },
        {
          "id": 53739,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">An increased GFR leads to lower serum creatinine levels</span></span></span></span></p>"
        },
        {
          "id": 53740,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Glycosuria may be seen in up to 50% of pregnant women</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which is not seen in pregnancy regarding renal changes in pregnancy?</span></span></span></p>",
      "unique_key": "Q8424591",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B.&nbsp; Pelvicalyceal dilatation is more on the left side than right side</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Physiological changes in the urinary system in pregnancy</span></span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kidneys</span></strong></span></span></span>\r\n\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in size by about 1.5 cm</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pelvicalyceal dilatation (Right &gt; left)</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased GFR leading to low creatinine, low BUN and low urea levels</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Total volume of urine passed is normal</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enzyme renin is increased</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ureter</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atonic, dilated (Right &gt; left)</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bladder</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mucosa become hyperemic and congested</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased frequency in the 1<sup>st</sup> and 3<sup>rd</sup> trimester</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SUI due to urethral sphincter weakness and decreased bladder capacity</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glycosuria</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">May be seen in up to 50% of pregnant women due to increase in GFR and decreases tubular reabsorption of glucose lowering the renal threshold</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proteinuria</span></strong></span></span></span>\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Significant proteinuria (&gt; 300mg/24h) is seen in preeclampsia</span></span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: Page no 55, Textbook of Obstetrics by JB Sharma</span></span></strong></span></span></p>",
      "correct_choice_id": 53738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13332,
      "choices": [
        {
          "id": 53289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolysis</span></span></span></p>"
        },
        {
          "id": 53290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated liver enzymes</span></span></span></p>"
        },
        {
          "id": 53291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombocytopenia</span></span></span></p>"
        },
        {
          "id": 53292,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retroplacental hemorrhage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not a part of HELLP syndrome?</span></span></span></p>",
      "unique_key": "Q3459094",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590371,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Retroplacental hemorrhage&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HELLP Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of &lt; 1,00,000/mm<sup>3</sup> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a rare complication of pregnancy induced hypertension.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may be associated even with mild hypertension and proteinuria</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Manifested by nausea, vomiting, epigastric or right upper quadrant pain, along with biochemical and hematological changes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parenchymal necrosis of liver causes elevation in hepatic enzymes (AST and ALT &gt; 70 IU/L and LDH &gt; 600 IU/L).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There may be subcapsular hematoma formation (which may need CT scanning) and abnormal peripheral smear.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eventually liver may rupture to cause sudden hypotension, due to hemoperitoneum.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s evaluate each option to identify the one that is not a part of HELLP syndrome:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hemolysis</span></strong><span style=\"font-size:12.0pt\">: Hemolysis refers to the breakdown of red blood cells, which is a key feature of HELLP syndrome. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Elevated Liver Enzymes</span></strong><span style=\"font-size:12.0pt\">: Elevated liver enzymes indicate liver dysfunction, which is another essential component of HELLP syndrome. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Thrombocytopenia</span></strong><span style=\"font-size:12.0pt\">: Thrombocytopenia is a significant reduction in platelet count, which is the third critical component of HELLP syndrome</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Retroplacental Hemorrhage</span></strong><span style=\"font-size:12.0pt\">: This is the correct answer. Retroplacental haemorrhage, also known as placental abruption, is a separate obstetric complication that involves the detachment of the placenta from the uterine wall before delivery. While it can be a serious condition, it is not a part of HELLP syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HELLP Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an acronym for Hemolysis (H), Elevated liver enzymes (EL) and Low Platelet count (LP) of &lt; 1,00,000/mm<sup>3</sup> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a rare complication of pregnancy induced hypertension.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may be associated even with mild hypertension and proteinuria</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 1849, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13313,
      "choices": [
        {
          "id": 53213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroprotection in preterm labor</span></span></span></p>"
        },
        {
          "id": 53214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe preeclampsia</span></span></span></p>"
        },
        {
          "id": 53215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tocolysis</span></span></span></p>"
        },
        {
          "id": 53216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe IUGR</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is NOT an indication of using this drug in obstetrics?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/30/picture1.jpg\" style=\"height:294px; width:500px\" /></span></span></span></span></p>",
      "unique_key": "Q1673546",
      "question_audio": null,
      "question_video": null,
      "map_id": 37590352,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Severe IUGR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO4 is used for the following obstetric indications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eclampsia &amp; severe preeclampsia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a tocolytic in preterm labor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For neuroprotection in very preterm</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Let&#39;s review each option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Neuroprotection in Preterm Labor:</span></strong><span style=\"font-size:12.0pt\"> Magnesium sulphate is used as a neuroprotective agent for the fetus in cases of imminent preterm birth (before 32 weeks of gestation). It helps in reducing the risk of cerebral palsy and other neurological impairments in premature infants. This is an established indication for the use of magnesium sulfate in obstetrics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Severe Preeclampsia</span></strong><span style=\"font-size:12.0pt\">: In cases of severe preeclampsia, magnesium sulfate is used for the prevention of seizures. It&#39;s a critical component of the management of severe preeclampsia and eclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tocolysis</span></strong><span style=\"font-size:12.0pt\">: Tocolysis refers to the use of medication to suppress premature labor. Magnesium sulfate has been used off-label as a tocolytic agent to delay preterm labor, although it&#39;s not the first-line treatment for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Severe IUGR (Intrauterine Growth Restriction)</span></strong><span style=\"font-size:12.0pt\">: IUGR refers to poor growth of the fetus while in the mother&#39;s womb during pregnancy. The management of IUGR primarily focuses on monitoring and timely delivery. Magnesium sulfate has no role in the treatment or management of IUGR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO4 is used for the following obstetric indications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eclampsia &amp; severe preeclampsia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a tocolytic in preterm labor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For neuroprotection in very preterm</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: page no 439, Textbook of Obstetrics, Dr JB Sharma 1<sup>st</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 53216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}